metformin has been researched along with wortmannin in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (40.00) | 29.6817 |
2010's | 3 (60.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Afshari, CA; Eschenberg, M; Hamadeh, HK; Lee, PH; Lightfoot-Dunn, R; Morgan, RE; Qualls, CW; Ramachandran, B; Trauner, M; van Staden, CJ | 1 |
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
Hamann, A; Yuan, L; Ziegler, R | 1 |
Holman, GD; Yang, J | 1 |
Garabadu, D; Krishnamurthy, S | 1 |
5 other study(ies) available for metformin and wortmannin
Article | Year |
---|---|
Interference with bile salt export pump function is a susceptibility factor for human liver injury in drug development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Assay; Biological Transport; Cell Line; Cell Membrane; Chemical and Drug Induced Liver Injury; Cytoplasmic Vesicles; Drug Evaluation, Preclinical; Humans; Liver; Rats; Reproducibility of Results; Spodoptera; Transfection; Xenobiotics | 2010 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Inhibition of phosphoenolpyruvate carboxykinase gene expression by metformin in cultured hepatocytes.
Topics: Androstadienes; Cells, Cultured; Gene Expression; Hepatocytes; Humans; Hypoglycemic Agents; Metformin; Phosphatidylinositol 3-Kinases; Phosphoenolpyruvate Carboxykinase (GTP); RNA, Messenger; Tumor Cells, Cultured; Wortmannin | 2002 |
Long-term metformin treatment stimulates cardiomyocyte glucose transport through an AMP-activated protein kinase-dependent reduction in GLUT4 endocytosis.
Topics: AMP-Activated Protein Kinases; Androstadienes; Animals; Biological Transport; Cell Membrane; Cells, Cultured; Endocytosis; Exocytosis; Glucose; Glucose Transporter Type 4; Hypoglycemic Agents; Male; Metformin; Multienzyme Complexes; Myocytes, Cardiac; Phosphorylation; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins c-akt; Rats; Rats, Wistar; Wortmannin | 2006 |
Metformin attenuates hepatic insulin resistance in type-2 diabetic rats through PI3K/Akt/GLUT-4 signalling independent to bicuculline-sensitive GABA
Topics: Androstadienes; Animals; Bicuculline; Calcium; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Glucose Transporter Type 4; Hypoglycemic Agents; Insulin Resistance; Male; Metformin; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; Rats; Receptors, GABA-A; Signal Transduction; Wortmannin | 2017 |